Cadila Pharmaceuticals

Cadila Pharmaceuticals – Chezgreen Division Launches Subhadra Syrup for Menstrual Health Support

Ahmedabad, May 27, 2026: Cadila Pharmaceuticals, one of India’s most respected pharmaceutical companies, through its Chezgreen Division, has announced the launch of Subhadra Syrup, a thoughtfully formulated herbal solution aimed at supporting women’s menstrual health. The syrup is designed to help regulate menstrual cycles and provide supportive care in managing common menstrual concerns such as amenorrhea, dysmenorrhea, and menorrhagia.

Drawing on the wisdom of traditional herbal knowledge and developed under stringent modern manufacturing standards, Subhadra Syrup offers a gentle yet effective option for women seeking natural support for menstrual well-being. With menstrual health issues continuing to impact the quality of life, comfort, and daily productivity of women across age groups, the launch addresses a significant and often under-discussed healthcare need.

Subhadra Syrup works by promoting hormonal balance and supporting uterine health through its carefully selected herbal ingredients, making it suitable for regular use as part of a holistic approach to women’s health.

Commenting on the launch, Dr. Rajiv I. Modi, Chairman & Managing Director, Cadila Pharmaceuticals Limited, said, “Women’s health, particularly menstrual well-being, deserves focused attention and compassionate solutions. With Subhadra Syrup, we have combined the strength of time-tested herbal knowledge with Cadila’s commitment to quality and scientific rigour. This launch reflects our continued efforts to offer safe, natural, and effective healthcare solutions that support women in leading healthier and more confident lives.”

Key benefits of Subhadra Syrup include:

  • Helps regularise menstrual cycles
  • Supports the management of amenorrhea (absence of menstruation)
  • Assists in relieving dysmenorrhea (painful menstruation)
  • Helps manage menorrhagia (heavy menstrual bleeding)

With this launch, the Chezgreen Division further strengthens Cadila Pharmaceuticals’ focus on holistic and preventive healthcare, reinforcing its mission to improve everyday health outcomes through trusted and accessible solutions.

downWhiteCurveArrow

Corporate Identification No : U24231GJ1991PLC015132

©2026 Cadila Pharmaceuticals. All rights reserved